This inventor holds 1 USPTO granted patent. Top assignees: Academia Sinica, Mello Biotech Taiwan Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 728 
1 out of 1 Years Active: 2026
Title: Mei-Jung Wang: Innovator in mRNA Technology
Introduction
Mei-Jung Wang is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of mRNA compositions for medical applications. His innovative work has the potential to impact both antiviral and anti-cancer vaccine development.
Latest Patents
Mei-Jung Wang holds a patent for a "Novel mRNA Composition and Production Method for Use in Anti-Viral and Anti-Cancer Vaccines." This patent highlights his expertise in creating advanced solutions for pressing health challenges.
Career Highlights
Throughout his career, Wang has worked with notable organizations, including Mello Biotech Taiwan Co., Ltd. and Academia Sinica. His experience in these institutions has allowed him to refine his skills and contribute to groundbreaking research in biotechnology.
Collaborations
Wang has collaborated with esteemed colleagues such as Shi-Lung Lin and Samantha Chang-Lin. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Mei-Jung Wang's contributions to mRNA technology exemplify the vital role of inventors in advancing medical science. His work not only addresses current health issues but also paves the way for future innovations in vaccine development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile